Terminated EARLY_PHASE1 INTERVENTIONAL 1-arm NCT01186185

Fludrocortisone for Sudden Hearing Loss

Mineralocorticoid Treatment for Sudden Sensorineural Hearing Loss

Sponsor: Oregon Health and Science University

Updated 7 times since 2017 Last updated: Oct 15, 2019 Started: Aug 31, 2012 Primary completion: Mar 31, 2016 Completion: Mar 31, 2016

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

PI moved to new institution, unable to complete study

Other terminated trials from Oregon Health and Science University

See all terminations from Oregon Health and Science University

This EARLY_PHASE1 trial investigates Hearing Loss, Sensorineural and is currently terminated or withdrawn. Oregon Health and Science University leads this study, which shows 7 recorded versions since 2012 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

7 versions recorded

Sep 2024 — Present [monthly]

Terminated EARLY_PHASE1
Jul 2024 — Sep 2024 [monthly]

Terminated EARLY_PHASE1
Jan 2021 — Jul 2024 [monthly]

Terminated EARLY_PHASE1
Nov 2019 — Jan 2021 [monthly]

Terminated EARLY_PHASE1

Status: Unknown Status → Terminated · Phase: NA → EARLY_PHASE1
Jun 2018 — Nov 2019 [monthly]

Unknown Status NA

▶ Show 2 earlier versions

May 2017 — Jun 2018 [monthly]

Unknown Status NA

Status: Recruiting → Unknown Status
Jan 2017 — May 2017 [monthly]

Recruiting NA

First recorded

Aug 2012

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Oregon Health and Science University

Data source: Oregon Health and Science University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Portland, United States